Correlation Among Symptom Score, Peak Urine Flow, Prostate Volume and Obstructive Parameters as analyzed in Pressure-Flow Studies for the Patients wth Benign Prostate Hyperplasia in Whom TURP will be Contemplated

1999 ◽  
Vol 3 (1) ◽  
pp. 41
Author(s):  
Kang-Soo Shim ◽  
Sung-Kun Koh ◽  
Jeong-Gu Lee
Keyword(s):  
Symptom Score ◽  
Benign Prostate Hyperplasia ◽  
Prostate Volume ◽  
Urine Flow ◽  
Pressure Flow ◽  
Prostate Hyperplasia ◽  
Pressure Flow Studies ◽  
Benign Prostate

scholarly journals Hubungan Prostate Volume dan Intravesical Prostatic Protrusion terhadap International Prostate Symptom Score pada Pasien Benign Prostate Hyperplasia (Relationship between Prostate Volume and Intravesical Prostatic Protrusion and International Prostate

2018 ◽  
Vol 6 (1) ◽  
pp. 97
Author(s):  
Rahma Illa Putri Utami ◽  
Septa Surya Wahyudi ◽  
Yuli Hermansyah
Keyword(s):  
Symptom Score ◽  
International Prostate Symptom Score ◽  
Benign Prostate Hyperplasia ◽  
Prostate Volume ◽  
P Value ◽  
Spearman Correlation ◽  
Prostate Hyperplasia ◽  
Transabdominal Ultrasonography ◽  
Benign Prostate ◽  
Intravesical Prostatic Protrusion

Diagnosis of benign prostate hyperplasia (BPH) can be established through transabdominal ultrasonography (TAUS), a noninvasive supportive examination which measure prostate volume (PV), and intravesical prostatic protrusion (IPP). The severity of obstructive symptoms experienced by the patient was assessed by international prostate symptom score (IPSS) questionnaire. This study aimed to analyse the relationship between both PV and IPP and IPSS in BPH patients. This was an observational analytic study with cross sectional design conducted at Department of Urology Surgery Bina Sehat Hospital Jember, Paru Hospital Jember and Bhayangkara Hospital Bondowoso during October-November 2016 in 30 respondents. The average of PV was 52.01±25.18 mL, IPP was 12.67±6.69 mm and IPSS score was 25.60±9.20. The results of Spearman correlation between the PV and Voiding-IPSS, Storage-IPSS, or total score IPSS and IPP and Voiding IPSS showed no significant correlation (p =0.319; p=0.067; p=0.085; p=0.183). Spearman correlation between the IPP and Storage-IPSS or total score IPSS resulted p value equal to 0.012 and r=0.451 and p=0.027 and r=0.404, which showed a significant correlation with moderate correlation strength. Statistically, IPP correlated to IPSS score better than PV.   Keywords: BPH, international prostate symptom score, transabdominal ultrasonography  

scholarly journals Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients

2017 ◽  
Vol 89 (1) ◽  
pp. 26 ◽  
Author(s):  
Levent Ozcan ◽  
Huseyin Besiroglu ◽  
Murat Dursun ◽  
Emre Can Polat ◽  
Alper Otunctemur ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Total Cholesterol ◽  
Symptom Score ◽  
Benign Prostate Hyperplasia ◽  
Prostate Volume ◽  
Total Testosterone ◽  
Diabetic Patients ◽  
Prostate Hyperplasia ◽  
Benign Prostate ◽  
Diagnosis Of Diabetes Mellitus

Objective: We evaluated the correlation between benign prostate hyperplasia (BPH) measures and diabetes mellitus in men with benign prostate hyperplasia in a prospective study. Materials and methods: Between 2008-2012, 100 diabetic and 200 non diabetic patients undergoing surgery due to benign prostate hyperplasia were enrolled in the study. The parameters evaluated for each patients included prostate volume, fasting blood glucose, HbA1c, total testosterone, total prostatic specific antigen (T-PSA), triglicerides, total cholesterol and body mass index (BMI). A questionnaire including international prostate symptom score (IPSS) was sdministered and uroflow test measuring the peak urinary flow rate was performed to appreciate the complaints of the patients objectively. Results: Diabetic patients are more likely to have larger prostate volume. The symptom score evaluated by IPSS and post micturition residual volume were also significantly higher in diabetic groups. The other statistically significant different parameter between two groups was total testosterone that diabetic patients tend to have lower levels. Diabetic counterparts were established to have higher BMI. No statistically significant differentiation was observed about trigliceryde and total cholesterol levels and uroflow rates. Conclusions: Our study suggests a positive correlation between high prostate volume and diagnosis of diabetes mellitus in patients with benign prostatic hyperplasia. We also observed a positive correlation between symptom scores and post micturion residual volumes and diagnosis of diabetes mellitus suggesting that the presence of diabetes is related to both static and dynamic components of benign prostate hyperplasia. Additionally testosterone levels were lower in diabetic patients. Further studies need to confirm these relationship in a larger population.

scholarly journals Association between benign prostate hyperplasia and metabolic syndrome in men under 60 years old: a meta-analysis

2019 ◽  
Vol 47 (11) ◽  
pp. 5389-5399
Author(s):  
Shuiqing Wu ◽  
Haiqing He ◽  
Yinhuai Wang ◽  
Ran Xu ◽  
Bin Zhu ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Web Of Science ◽  
Benign Prostate Hyperplasia ◽  
Prostate Volume ◽  
Meta Analysis ◽  
Prostate Hyperplasia ◽  
Younger Men ◽  
Key Words Metabolic Syndrome ◽  
Benign Prostate

Objective To assess the potential relationship between benign prostate hyperplasia (BPH) and metabolic syndrome in men under 60 years old. Methods We searched the Medline, Embase, and Web of Science databases for studies of patients with metabolic syndrome and BPH using the key words ‘metabolic syndrome’, ‘benign prostatic hyperplasia’, and ‘BPH’. The odds ratios (ORs) and 95% confidence intervals (95%CIs) were extracted from the included studies and the role of metabolic syndrome in BPH and its characteristics (International Prostate Symptom Score (IPSS), total prostate volume (TPV), postvoid residual (PVR)) were evaluated by meta-analysis. Results Six comparative studies comprising 61,826 individuals were identified and included in this meta-analysis. There were significant correlations between metabolic syndrome and BPH (OR = 1.24, 95%CI = 1.19–1.29), clinical BPH (OR = 1.37, 95%CI = 1.03–1.70), and TPV (OR = 2.34, 95%CI = 1.25–3.42). However, there was no significant association between metabolic syndrome and IPSS (OR = 1.19, 95%CI = 0.35–2.04) or PVR (OR = 2.15, 95% CI = 0.95–3.34). Conclusions These results indicate that metabolic syndrome is significantly and positively correlated with the incidence of BPH in younger men aged <60 years. However, there was no significant relationship between metabolic syndrome and BPH-related symptoms.

scholarly journals Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study

2019 ◽  
Vol 6 (1) ◽  
Author(s):  
Lan Wu ◽  
Bing-Hui Li ◽  
Yun-Yun Wang ◽  
Chao-Yang Wang ◽  
Hao Zi ◽  
...  
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Periodontal Disease ◽  
Subgroup Analysis ◽  
Benign Prostate Hyperplasia ◽  
Prostate Volume ◽  
Prostatic Hyperplasia ◽  
Health Examination ◽  
Control Analysis ◽  
Prostate Hyperplasia ◽  
Benign Prostate

Abstract Background Both periodontal disease and benign prostatic hyperplasia are age-related diseases that affect millions of people worldwide. Hence, this study aimed to investigate the association between periodontal disease and the risk of benign prostatic hyperplasia. Methods A total of 4930 participants were selected from an available health examination that was carried out in 2017, only males were considered for further analysis. All eligible males were divided into benign prostatic hyperplasia and normal groups, the benign prostatic hyperplasia group was then divided into prostate volume ≤ 60 g and > 60 g subgroups; all their periodontal status was extracted and then into normal (CPI score of 0), periodontal disease (CPI score between 1 and 4), and periodontitis (CPI score between 3 and 4) groups. The correlation between periodontal disease and benign prostatic hyperplasia was investigated using logistic regression analyses and greedy matching case-control analysis. Subgroup analysis based on prostate volume was also performed. All analyses were conducted with SAS 9.4 software. Results A total of 2171 males were selected for this analysis. The presence of periodontal disease significantly increased the risk of benign prostatic hyperplasia by 1.68 times (OR = 1.68, 95% CI: 1.26–2.24), and individuals with periodontitis showed a higher risk (OR = 4.18, 95% CI: 2.75–6.35). In addition, among matched cases and controls, this association remained robust (periodontal disease: OR = 1.85, 95% CI: 1.30–2.64; periodontitis: OR = 4.83, 95% CI: 2.57–9.07). Subgroup analysis revealed that periodontal disease significantly increased benign prostate hyperplasia risk as well (for prostate volume ≤ 60 g: OR = 1.64, 95% CI: 1.22–2.20; for volume > 60 g: OR = 2.17, 95% CI: 1.04–4.53), and there was a higher risk in the group with a prostate volume greater than 60 g. Conclusion Periodontal disease is significantly and positively associated with an increased risk of benign prostatic hyperplasia. Further validation studies should be performed to explore the relationship between periodontal treatment and benign prostate hyperplasia.

scholarly journals THE CORRELATIONS AMONG COMPONENTS OF METABOLIC SYNDROME PSA AND PROSTATE VOLUME IN BPH PATIENTS

2016 ◽  
Vol 23 (2) ◽  
Author(s):  
Yanuar Wicaksana Sumasta ◽  
Danarto Danarto
Keyword(s):  
Metabolic Syndrome ◽  
Blood Glucose ◽  
Benign Prostate Hyperplasia ◽  
Prostate Volume ◽  
Specific Antigen ◽  
Adult Treatment Panel ◽  
Prostate Hyperplasia ◽  
Transabdominal Ultrasonography ◽  
Benign Prostate ◽  
Total P

Objective: This study was to evaluate the associations among metabolic components, prostate specific antigen (PSA), and prostate volume (PV) in benign prostate hyperplasia (BPH) patients.Material & method: During the period from January 1, 2010 to August 31, 2013, 61 mens were diagnosed with BPH were enrolled. PV by transabdominal ultrasonography of the prostate, serum PSA, metabolic syndrome (MS) related parameters were investigated. MS was defined according to the modified National Cholesterol Education Program Third Adult Treatment Panel Guidelines. We evaluated the correlation between PSA, PV and MS components using Spearman’s test and Independent t test.Results: PV were not correlated with MS criteria (p=0.591) PSA total also were not correlated with MS criteria (p=0.305). PV were not correlated with each components MS; cholesterol total (p=0.593), trigliserid (p=0.479), HDL (p=0.702), LDL (p=0.512), blood glucose (p=0.317). PSA total were not correlated with each components MS; cholesterol total (p=0.255), trigliserid (p=0.543), HDL (p=0.446), LDL (p=0.615), blood glucose (p=0.987). Conclusion: There were no associations among metabolic syndrome criteria and each components, prostate volume and PSA total.

Sign in / Sign up

Export Citation Format

Share Document